166-180 of 372
The Benefits of TZDs for Early Type 2 Diabetes
Diabetes DiscourseThe Benefits of TZDs for Early Type 2 Diabetes
John (Jack) L. Leahy, MD
Steven Edelman, MD
Oral Agents for Diabetes: What to Choose and When
Diabetes DiscourseOral Agents for Diabetes: What to Choose and When
Andrew Ahmann, MD
Steven Edelman, MD
Report From Capitol Hill with AMA Board Chair Dr. Rebecca Patchin
Second Opinion LIVE!Report From Capitol Hill with AMA Board Chair Dr. Rebecca Patchin
Rebecca Patchin, MD
Joseph Kim, MD, MPH
Matt Birnholz, MD
Michael Greenberg, MD
The Battle Continues Against Pharmacological Cheating in Sports
Focus on Sports MedicineThe Battle Continues Against Pharmacological Cheating in Sports
Gary Wadler, MD
Bruce Japsen
Darrel Regier, MD
Bruce Japsen
Multiple Choice: Customizing Insulin Therapy
Diabetes DiscourseMultiple Choice: Customizing Insulin Therapy
Matthew Riddle, MD
Steven Edelman, MD
- advertisement
As Prescribed: Meeting the Challenges of Medication Adherence
Heart MattersAs Prescribed: Meeting the Challenges of Medication Adherence
Janet Wright, MD
Michael Ho, MD, PhD
In-Office Drug Testing for Retinal Conditions
Revealing RetinaIn-Office Drug Testing for Retinal Conditions
Roy Levit, MD
Allen Verne, MD
Debra Simmons, MD
Steven Edelman, MD
The Potential of Immunotherapy in Type 1 Diabetes
Diabetes DiscourseThe Potential of Immunotherapy in Type 1 Diabetes
Matthias von Herrath, MD
Steven Edelman, MD
Nancy Bohannon, MD
Steven Edelman, MD
Interventions Targeting Impaired Glucose Tolerance
Diabetes DiscourseInterventions Targeting Impaired Glucose Tolerance
Robert Henry, MD
Steven Edelman, MD
- advertisement
The ARBITER 6-HALTS Trial: Clinical Implications
Heart MattersThe ARBITER 6-HALTS Trial: Clinical Implications
Christopher Cannon, MD
Jack Lewin, MD
Are Out-of-State Provider Licensing Laws Due for a Change?
Second Opinion LIVE!Are Out-of-State Provider Licensing Laws Due for a Change?
Stan Brock
Matt Birnholz, MD
Michael Greenberg, MD
How Will Pharmacogenomics Play a Role in Diabetes Therapy?
Diabetes DiscourseHow Will Pharmacogenomics Play a Role in Diabetes Therapy?
Joseph Ma, PharmD
Steven Edelman, MD